Speaker illustration

Doctor Tomonari Kimura

Fukuyama Cardiovascular Hospital, Fukuyama (Japan)

Effects of Tofogliflozin, an Sodium-glucose co-transporter 2 Inhibitor, on Cardiac Hypertrophy in Metabolic Model Rats

Event: ESC Congress 2017

Topic: Drug therapy

Session: Inflammation, diabetes and their influence on the heart

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb